A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

September 30, 2008

Conditions
Chemotherapy-Induced ThrombocytopeniaHodgkin's LymphomaNon-Hodgkin's LymphomaCancerOncologyThrombocytopenia
Interventions
BIOLOGICAL

AMG 531

"Planned Cohorts:~1. 100 mcg,~2. 300 mcg,~3. 700 mcg,~4. 1000 mcg;~ Optional Cohorts:~5. cohort expansion,~6. schedule change,~7. new dose"

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY